-
Osobe Vidi sve
Ovjeren akaunt@GSK Latest news and views from science-led global healthcare company GSK. Run by the global digital comms team. Code of Conduct: http://gsk.to/1OCpCfJ
London, UK • gsk.com
-
Gilead's Ebola Drug Shows Positive Signs in Treating Coronavirus
@themotleyfool#stocks$GILD$JNJ$GSK$ABBV$INO$MRNAhttps://www.fool.com/investing/2020/02/03/gileads-ebola-drug-shows-positive-signs-in-treatin.aspx … -
-
short ratio of
$EBS is 7.23 at 2019-05-31 http://sunshineavenue.com/stock/EBS/$PFE 2.86$MRK 1.89$GSK 2.34 -
-
GSK full-year results: where next for the share price?
$GSK#shares https://bddy.me/2GRUECU pic.twitter.com/dRQukplHfd
-
$GSK#Pharmaceuticals Head Luke Miels talked to S&P Global Market Intelligence about leading the U.K. company down a new road in#cancer, and the R&D philosophy that got them there: http://ow.ly/YcOR50yc3ZV pic.twitter.com/odJN50UieF
-
-
$PFE$NVS$GSK$REGN: Is a Disappointment in Store for Glaxo’s (GSK) Q4 Earnings?: https://www.StockNewsWires.com/pfe-nvs-gsk-regn-is-a-disappointment-in-store-for-glaxos-gsk-q4-earnings/ … -
Start with your free watchlist for
#FTSE 100$LLOY$GSK$BATS http://www.cityfalcon.com/watchlists?name=FTSE%20100%20Tracker&utm_campaign=T_AT …pic.twitter.com/jg911UEKzI
-
GlaxoSmithKline partners with CEPI to make vaccine adjuvant technology available to combat 2019nCoV httpswww.firstwordpharma.comnode1697877Â
$GSK: GlaxoSmithKline partners with CEPI to make vaccine adjuvant technology available to combat 2019nCoV… http://bioportfol.io/RPHPFT -
According to the technical breakouts screen,
$BKI,$JNUG and$GSK are showing a decent breakout pattern for today. https://www.chartmill.com/stock/stock-screener?sid=202&f=v1_50b500,atrpct_a_1,sl_ta_7_X,sl_se_7_X,p_pg20,exch_us&s=se&v=3&utm_source=twitterUS&utm_medium=screener&utm_content=Stock_Screener:_Technical_Breakout_Setups&utm_campaign=social_tracking … -
-
-
-
$MRK$GSK$REGN$GILD: Will Strong HIV Sales Drive Gilead’s (GILD) Q4 Earnings?: https://www.StockNewsWires.com/mrk-gsk-regn-gild-will-strong-hiv-sales-drive-gileads-gild-q4-earnings/ … -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.